599 related articles for article (PubMed ID: 25789543)
1. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.
Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE
J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543
[TBL] [Abstract][Full Text] [Related]
2. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy.
Mondello S; Shear DA; Bramlett HM; Dixon CE; Schmid KE; Dietrich WD; Wang KK; Hayes RL; Glushakova O; Catania M; Richieri SP; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):595-605. PubMed ID: 26671651
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Dixon CE; Bramlett HM; Dietrich WD; Shear DA; Yan HQ; Deng-Bryant Y; Mondello S; Wang KK; Hayes RL; Empey PE; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):553-66. PubMed ID: 26671075
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury.
Zoltewicz JS; Mondello S; Yang B; Newsom KJ; Kobeissy F; Yao C; Lu XC; Dave JR; Shear DA; Schmid K; Rivera V; Cram T; Seaney J; Zhang Z; Wang KK; Hayes RL; Tortella FC
J Neurotrauma; 2013 Jul; 30(13):1161-9. PubMed ID: 23409698
[TBL] [Abstract][Full Text] [Related]
5. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Shear DA; Dixon CE; Bramlett HM; Mondello S; Dietrich WD; Deng-Bryant Y; Schmid KE; Wang KK; Hayes RL; Povlishock JT; Kochanek PM; Tortella FC
J Neurotrauma; 2016 Mar; 33(6):523-37. PubMed ID: 26670792
[TBL] [Abstract][Full Text] [Related]
8. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Browning M; Shear DA; Bramlett HM; Dixon CE; Mondello S; Schmid KE; Poloyac SM; Dietrich WD; Hayes RL; Wang KK; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):581-94. PubMed ID: 26671550
[TBL] [Abstract][Full Text] [Related]
10. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and αII-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats.
DeDominicis KE; Hwang H; Cartagena CM; Shear DA; Boutté AM
Front Neurol; 2018; 9():490. PubMed ID: 30022967
[TBL] [Abstract][Full Text] [Related]
12. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
Korley F; Pauls Q; Yeatts SD; Jones CMC; Corbett-Valade E; Silbergleit R; Frankel M; Barsan W; Cahill ND; Bazarian JJ; Wright DW
J Neurotrauma; 2021 Jul; 38(14):1953-1960. PubMed ID: 33319651
[TBL] [Abstract][Full Text] [Related]
13. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
14. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Mountney A; Bramlett HM; Dixon CE; Mondello S; Dietrich WD; Wang KK; Caudle K; Empey PE; Poloyac SM; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM; Shear DA
J Neurotrauma; 2016 Mar; 33(6):567-80. PubMed ID: 26541177
[TBL] [Abstract][Full Text] [Related]
16. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
17. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
18. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
20. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
